isoproterenol has been researched along with suramin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellan, C; Fantini, J; Marvaldi, J; Pic, P; Pichon, J | 1 |
| Akkermans, LM; Briejer, MR; Lefebvre, RA; Meulemans, AL; Schuurkes, JA | 1 |
| Bültmann, R; Driessen, B; Gonçalves, J; Starke, K | 1 |
| Habuchi, Y; Morikawa, J; Nishio, M; Tanaka, H; Yamamoto, T | 1 |
| Jenkinson, KM; Reid, JJ | 1 |
| Gu, X; Sagawa, M; Sakuda, M; Sakuma, T; Sugita, M; Toga, H | 1 |
| Arvola, L; Bertelsen, G; Hassaf, D; Ytrehus, K | 1 |
| Novotny, J; Stöhr, J; Svoboda, P | 1 |
| Antal, A; Barthó, L; Benkó, R; Csontos, Z; Horváth, OP; Illényi, L; Undi, S; Vereczkei, A; Wolf, M | 1 |
11 other study(ies) available for isoproterenol and suramin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines.
Topics: Cross-Linking Reagents; Cyclic AMP; Humans; Iodine Radioisotopes; Isoproterenol; Protein Binding; Receptors, Gastrointestinal Hormone; Receptors, Vasoactive Intestinal Peptide; Succinimides; Suramin; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1991 |
5-HT-induced neurogenic relaxations of the guinea-pig proximal colon: investigation into the role of ATP and VIP in addition to nitric oxide.
Topics: Adenosine Triphosphate; Animals; Apamin; Colon; Female; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Nitroglycerin; Serotonin; Suramin; Vasoactive Intestinal Peptide | 1995 |
Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: evidence for the beta 2 subtype.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Imidazoles; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth; Neuromuscular Junction; Norepinephrine; Prazosin; Propanolamines; Receptors, Adrenergic, beta-2; Suramin; Terbutaline; Vas Deferens | 1996 |
P2 purinoceptors contribute to ATP-induced inhibition of L-type Ca2+ current in rabbit atrial myocytes.
Topics: 1-Methyl-3-isobutylxanthine; 5'-Nucleotidase; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Calcium-Transporting ATPases; Colforsin; Cyclic AMP; Enzyme Inhibitors; Isoproterenol; Myocardium; Patch-Clamp Techniques; Pertussis Toxin; Potassium Channels; Potassium Channels, Voltage-Gated; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rabbits; Receptors, Purinergic P2; Shal Potassium Channels; Suramin; Virulence Factors, Bordetella; Xanthines | 1999 |
The P(2)-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Binding, Competitive; Drug Interactions; Gastric Fundus; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Neuropeptides; Nitric Oxide; Nitroprusside; Pituitary Adenylate Cyclase-Activating Polypeptide; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Vasoactive Intestinal Peptide; Suramin; Vasoactive Intestinal Peptide; Vasodilator Agents | 2000 |
Uridine 5'-triphosphate stimulates alveolar fluid clearance in the isolated rat lungs.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Drug Interactions; Extravascular Lung Water; Glyburide; In Vitro Techniques; Isoproterenol; Male; Nitrobenzoates; Propranolol; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Suramin; Uridine Triphosphate | 2004 |
Positive inotropic and sustained anti-beta-adrenergic effect of diadenosine pentaphosphate in human and guinea pig hearts. Role of dinucleotide receptors and adenosine receptors.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dinucleoside Phosphates; Female; Guinea Pigs; Heart Atria; Humans; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Purinergic Antagonists; Receptors, Purinergic P2; Suramin; Theophylline; Vasoconstrictor Agents | 2004 |
Characterization of [3H]-forskolin binding sites in young and adult rat brain cortex: identification of suramin as a competitive inhibitor of [3H]-forskolin binding.
Topics: Adrenergic beta-Agonists; Aging; Animals; Baclofen; Binding, Competitive; Cell Membrane; Cerebral Cortex; Colforsin; GABA Agonists; Guanylyl Imidodiphosphate; Isoproterenol; Magnesium; Male; Rats; Rats, Wistar; Receptors, Drug; Suramin | 2005 |
Purinergic nerves mediate the non-nitrergic relaxation of the human ileum in response to electrical field stimulation.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Electric Stimulation; Enteric Nervous System; Enzyme Inhibitors; Humans; Ileum; Isoproterenol; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Purinergic P2 Receptor Antagonists; Purines; Pyridoxal Phosphate; Receptors, Purinergic P2; Suramin | 2006 |